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Introduction: Cystic ﬁbrosis is the most common autosomal recessive disease in
Caucasian populations. The aim of this study was to perform genetic analysis and
to identify CFTR mutations in patients from the National Center of Cystic Fibrosis
from Timisoara.
Material and Methods: Based on clinical ﬁndings and sweat test, 46 patients
(92 alleles) were selected for performing genetic testing. 29 mutations were investi-
gated and the detection was performed using the Elucigene CF29 kit which detects
point mutations or small deletions in deoxyribonucleic acid using a method based
on ARMS (ampliﬁcation refractory mutation system) allele speciﬁc ampliﬁcation
technology. Genomic DNA isolated from peripheral blood samples was ampliﬁed
by PCR and the PCR products were visualized on a UV transiluminator after
electrophoresis on agarose gel and staining with ethidium bromide.
Results: 5 mutations were identiﬁed: DF508, G542X, N1303K, I148T and 621 +
1G>T. 39 alleles (42.4%) remained unidentiﬁed. The frequency of CFTR mutations
was calculated.
Conclusions: In Romanian population the most frequent CFTR mutations are
DF508 (46.8%) and G542X (6.52%), these two mutations having the highest
frequency in Europe. Many mutations remain unidentiﬁed by investigating only
the 29 mutations panel from Elucigene CF29 kit. The great number of mutations
and polymorphisms (25) identiﬁed up to date by this study and previous studies,
reﬂects the genetic heterogeneity of Romanian population.
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Cystic ﬁbrosis (CF) is mainly caused by small molecular lesions of the CFTR gene,
but a number of CF patients still remain uncharacterized using PCR-techniques. The
CF mutation database (www.genet.sickkids.on.ca) lists more than 25 large deletions
encompassing one or more exons, and a single case of duplication.
We report here the results of our screening for CTFR gene rearrangements,
performed on Italian CF patients.
A sample of 689 unrelated Italian patients (for a total of 1378 alleles), followed
at CF Center of Regione Lombardia (Milan, Italy), was collected. All patients had
a classical form of CF with typical pulmonary and gastrointestinal symptoms, and
positive sweat test.
The Innogenetics assay and the DHPLC screening showed a mutation detection rate
of 93%. After these analyses, 100 alleles still remain unidentiﬁed (7%).
In order to detect the rearrangements in the CFTR gene, the 27 exons were screened
in these patients with the MLPA assay based on commercial Kit “SALSA P091
CFTR MALPA Kit”. The MLPA assay was performed for 38 patients (76 alleles).
We characterized 10 different deletions for a total of 19 deleted alleles. Taking
into account the total number of CF alleles, 25% (19/76) alleles had a large gene
deletion. The deletion of exons 22−23 (6/76) is the most frequent in our population.
In conclusion, analysis of CF patients performed with MLPA techniques have made
possible to reach a 94.4% detection rate, improving the process of carrier detection
and genetic counselling in Italian population.
Supported by: Ministry of Health and Regione Lombardia.
7 GT repetition on 5T allele
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5T allele over the introne 8 of CFTR gene represents the second most frequent
mutation of CFTR gene and it seems to be expressed on 10% of general population.
It is characterised by a variable penetrance and its clinical expression is related to be
in trans position with a mayor CFTR mutation. In this kind of genetic pattern some
clinical features such as different agenesis, nasal poliposis, recurrent pancreatitis,
bronchiectasie and neonatal ipertripsinemia seems to be more frequent leading to
a typical form of Cystic Fibrosis.
We conﬁrm this kind of clinical pattern in two familiar cases; one in a child of
14 years old with an important story of recurrent sinusitis and endoscopic features
of nasal poliposis. His sweet test resulted border line (Na 59mEq/l, Cl 57mEq/l)
with a genetic evaluation demonstrating dele2,3 (21Kb)(GT)11-(GT)12T5 with
polyT 5/7 genotype. His father resulted (GT)10T7-(GT)12T5 and appeared symp-
tomatic while his mother, whose genetic characterisation is dele2,3 (21Kb)(GT)11-
(GT)11T5, presented with an autoimmune disorder such as pernicious anaemia.
Surely a bigger sample of data will be necessary to investigate the hypothesis of
a genotype-phenotype correlation but the genetic pattern of this family seems to
suggest that bad clinical features are related to more GT repetition on 5T allele.
(Sequence evaluation of other 5 patients with 5T allele is on stand).
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Cystic Fibrosis is a common autosomal recessive disorder that primarily affects
the epithelial cells in the intestine, respiratory system, pancreas, gall bladder and
sweat glands. The frequency of CF in the German population is 1:3300. Over
1400 mutations and more than 200 polymorphisms have currently been identiﬁed
in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene that
are associated with CF disease. Many without recognised effects on CFTR, the
molecular diagnosis can be troublesome. The CF phenotype is highly heteroge-
neous among individual patients, even between siblings carrying identical CFTR
mutations. The aim of our study was to develop a highly sensitive, automated and
economical molecular pre-screening method based on denaturing high performance
liquid chromatography (DHPLC) for analyse the complete coding sequence of the
CFTR gene (24 exons). Complete automated sequencing, the standard procedure,
however, is time consuming, laborious and expensive. We have tested 108 patients
from the CF-DNA bank from the Institute of Human Genetics, University of Leipzig
(including 21 cases with one molecular genetic conﬁrmed CF mutation as positive
control). Following PCR and heteroduplexformation, all 24 exons of the CFTR
gene were screened for mutations or polymorphisms using DHPLC. We found 37
nucleotide changes including mutations (8) on 11 alleles and polymorphisms (29,
including 6 novel variants) on 430 alleles. DHPLC has proofed again to be important
for large gene mutation screening. With this technology efﬁcient and fast screening
for point mutations can be applied.
